Mather Group, LLC.
- SEC CIK
- 0001527641
- Latest filing
- Jul 27, 2026
BCRX holding history
Biocryst Pharmaceuticals Inc in every 13F filed by Mather Group, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −355−100.0% | Sold out | Holders |
| Q3 2025 | 355 | $2.69K | <0.1% | +355 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −355−100.0% | Sold out | Holders |
| Q1 2025 | 355 | $2.66K | <0.1% | +355 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −355−100.0% | Sold out | Holders |
| Q2 2024 | 355 | $1.80K | <0.1% | +155+77.5% | Added | Holders |
| Q1 2024 | 200 | $1.20K | <0.1% | +200 | New | Holders |